CORCEPT THERAPEUTICS INC Quarterly Other Assets, Noncurrent in USD from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Corcept Therapeutics Inc quarterly Other Assets, Noncurrent history and growth rate from Q4 2010 to Q3 2024.
  • Corcept Therapeutics Inc Other Assets, Noncurrent for the quarter ending September 30, 2024 was $6.97M, a 6.62% increase year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $6.97M +$433K +6.62% Sep 30, 2024 10-Q 2024-10-30
Q2 2024 $6.94M +$2.53M +57.2% Jun 30, 2024 10-Q 2024-07-29
Q1 2024 $6.39M +$1.62M +34.1% Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $6.54M +$1.48M +29.3% Dec 31, 2023 10-Q 2024-10-30
Q3 2023 $6.54M +$1.46M +28.7% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $4.41M +$2.58M +141% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $4.76M +$1.78M +59.7% Mar 31, 2023 10-Q 2023-05-03
Q4 2022 $5.06M +$1.98M +64.1% Dec 31, 2022 10-K 2024-02-15
Q3 2022 $5.08M +$975K +23.7% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $1.83M -$2.31M -55.7% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $2.98M -$2.05M -40.7% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $3.08M -$1.92M -38.3% Dec 31, 2021 10-K 2023-02-28
Q3 2021 $4.11M -$904K -18% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $4.14M -$396K -8.73% Jun 30, 2021 10-Q 2021-07-29
Q1 2021 $5.03M +$1.59M +46.2% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $5M +$1.55M +45% Dec 31, 2020 10-K 2022-02-15
Q3 2020 $5.01M +$4.86M +3240% Sep 30, 2020 10-Q 2020-11-03
Q2 2020 $4.54M +$4.39M +2924% Jun 30, 2020 10-Q 2020-08-04
Q1 2020 $3.44M +$3.37M +4488% Mar 31, 2020 10-Q 2020-05-04
Q4 2019 $3.45M +$3.4M +6796% Dec 31, 2019 10-K 2021-02-23
Q3 2019 $150K +$97K +183% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $150K +$97K +183% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $75K +$2K +2.74% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $50K $0 0% Dec 31, 2018 10-K 2020-02-24
Q3 2018 $53K -$12.9M -99.6% Sep 30, 2018 10-Q 2018-11-02
Q2 2018 $53K +$4K +8.16% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 $73K +$24K +49% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 $50K +$26K +108% Dec 31, 2017 10-K 2019-02-26
Q3 2017 $13M +$13M +54021% Sep 30, 2017 10-Q 2017-11-03
Q2 2017 $49K +$25K +104% Jun 30, 2017 10-Q 2017-08-02
Q1 2017 $49K +$24K +96% Mar 31, 2017 10-Q 2017-05-02
Q4 2016 $24K $0 0% Dec 31, 2016 10-K 2018-02-28
Q3 2016 $24K -$41K -63.1% Sep 30, 2016 10-Q 2016-11-02
Q2 2016 $24K -$47K -66.2% Jun 30, 2016 10-Q 2016-08-03
Q1 2016 $25K -$53K -67.9% Mar 31, 2016 10-Q 2016-05-04
Q4 2015 $24K -$50K -67.6% Dec 31, 2015 10-K 2017-03-06
Q3 2015 $65K -$16K -19.8% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 $71K -$16K -18.4% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 $78K -$18K -18.8% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 $74K -$39K -34.5% Dec 31, 2014 10-K 2016-03-10
Q3 2014 $81K -$39K -32.5% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 $87K -$41K -32% Jun 30, 2014 10-Q 2014-08-08
Q1 2014 $96K -$40K -29.4% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 $113K -$31K -21.5% Dec 31, 2013 10-K 2015-03-13
Q3 2013 $120K -$40K -25% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 $128K -$132K -50.8% Jun 30, 2013 10-Q 2013-08-09
Q1 2013 $136K +$64K +88.9% Mar 31, 2013 10-Q 2013-05-08
Q4 2012 $144K +$112K +350% Dec 31, 2012 10-K 2014-03-14
Q3 2012 $160K +$120K +300% Sep 30, 2012 10-Q 2012-11-08
Q2 2012 $260K +$228K +713% Jun 30, 2012 10-Q 2012-08-09
Q1 2012 $72K Mar 31, 2012 10-Q 2012-05-10
Q4 2011 $32K -$72K -69.2% Dec 31, 2011 10-K 2013-03-15
Q3 2011 $40K Sep 30, 2011 10-Q 2011-11-08
Q2 2011 $32K Jun 30, 2011 10-Q 2011-08-09
Q4 2010 $104K Dec 31, 2010 10-K 2012-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.